Nautilus Biotechnology Inc

Research Nautilus Biotechnology Inc (NAUT) on Bullrun: market cap USD 227.47M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerNAUT
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 227.47M
• Financial periodFY2025
• Net income-USD 59.00M
• Free cash flow-USD 51.97M

Valuation Snapshot

latest market cap is USD 227.47M.

About Nautilus Biotechnology Inc

Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome in the United States. The company develops Nautilus Voyager Platform, which includes an end-to-end solution comprising instruments, reagents, consumables, and software analysis.

Frequently asked questions

What is Nautilus Biotechnology Inc's market cap?

Nautilus Biotechnology Inc's market capitalization is USD 227.47M.

What does Nautilus Biotechnology Inc do?

Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome in the United States.